Drug Interactions

atorvastatin Drug Interactions

Also known as: atorvastatin calcium, Lipitor, Atorvastatin Calcium

Atorvastatin (Lipitor) is a medication that belongs to a class of drugs called statins. It is primarily used to lower high cholesterol levels in the blood and reduce the risk of serious heart problems like heart attack and stroke. It works by helping your body produce less cholesterol.atorvastatin has 2 documented drug interactions in our database, including 0 contraindicated, 1 major, 1 moderate, and 0 minor interactions.

0

Contraindicated

1

Major

1

Moderate

0

Minor

CLARITHROMYCIN(Clarithromycin)
Major

Clarithromycin significantly increases atorvastatin exposure, raising the risk of myopathy and rhabdomyolysis.

Mechanism

Clarithromycin is a potent CYP3A4 inhibitor, reducing atorvastatin first-pass metabolism and increasing plasma levels up to 4-fold.

Clinical Management

Temporarily suspend atorvastatin during short courses of clarithromycin, or use a non-CYP3A4 statin (pravastatin, rosuvastatin).

Evidence: established
Source: RxGuide-CuratedCompare these drugs
rosuvastatin(ROSUVASTATIN CALCIUM)
Moderate

Concomitant use of atorvastatin and rosuvastatin is generally not recommended as it significantly increases the risk of dose-dependent statin-related adverse effects, particularly myopathy and rhabdomyolysis, without providing substantial additional lipid-lowering benefit. While both drugs lower cholesterol, combining them primarily elevates safety concerns.

Mechanism

Both atorvastatin and rosuvastatin are HMG-CoA reductase inhibitors, and their co-administration leads to an additive pharmacological effect, increasing systemic exposure to statins. This heightened exposure saturates metabolic pathways and increases the likelihood of dose-related toxicities, especially muscle-related adverse events.

Clinical Management

The co-administration of atorvastatin and rosuvastatin should generally be avoided. If a patient requires more intensive lipid lowering than a single statin can provide, alternative strategies such as increasing the dose of a single statin (within recommended limits), or adding a non-statin lipid-lowering agent (e.g., ezetimibe, PCSK9 inhibitor) should be considered. Monitor patients closely for muscle pain, tenderness, or weakness if this combination is inadvertently used.

Evidence: established
Onset: delayed
Source: RxGuide-LLMCompare these drugs

For complete prescribing information:

View full atorvastatin monograph →

Medical Disclaimer

The information on RxGuide is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pharmacist, or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.